Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib

Kai Deng(Sun Yat-sen University), S Z Wang(Longgang Central Hospital)
Biochemistry and Biophysics Reports
July 7, 2024
10.1016/j.bbrep.2024.101781
Cited by 2

Related Papers

Ponatinib Represses Latent HIV-1 by Inhibiting AKT-mTOR
|Antimicrobial Agents and Chemotherapy|2023|14
Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR
|Acta Pharmacologica Sinica|2024|8